Judge Hands SEC Win In Pharma Co.'s CBD Investor Fraud Case
By Katryna Perera · November 25, 2025, 4:09 PM EST
A California federal judge has granted the U.S. Securities and Exchange Commission an early win in its suit against Vivera Pharmaceuticals, its CEO and affiliate Sentar Pharmaceuticals, finding they misled investors...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login